Approval · Notice of Compliance 33912 · 2024
ARMLUPEG: Notice of Compliance 33912
Issued August 16, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33912
- Date
- August 16, 2024
- Company
- Lupin Pharma Canada LimitedLongueuil, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Canadian reference product
- NEULASTA
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ARMLUPEG | Not yet assigned | — |
Medicinal ingredients
- PEGFILGRASTIM 6 MG per 0.6ML